Nomura Holdings Inc. lifted its stake in Albemarle Corporation (NYSE:ALB) by 57.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,320 shares of the specialty chemicals company’s stock after buying an additional 3,025 shares during the period. Nomura Holdings Inc.’s holdings in Albemarle Corporation were worth $879,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Albemarle Corporation by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock worth $102,000 after buying an additional 20 shares during the period. Carroll Financial Associates Inc. increased its holdings in shares of Albemarle Corporation by 0.3% in the second quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock worth $103,000 after buying an additional 3 shares during the period. Highlander Capital Management LLC purchased a new position in shares of Albemarle Corporation in the second quarter worth about $106,000. Smithfield Trust Co. increased its holdings in shares of Albemarle Corporation by 16.1% in the second quarter. Smithfield Trust Co. now owns 1,008 shares of the specialty chemicals company’s stock worth $106,000 after buying an additional 140 shares during the period. Finally, Benjamin F. Edwards & Company Inc. increased its holdings in shares of Albemarle Corporation by 0.3% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,458 shares of the specialty chemicals company’s stock worth $154,000 after buying an additional 4 shares during the period. Hedge funds and other institutional investors own 83.67% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/10/19/nomura-holdings-inc-has-879000-stake-in-albemarle-corporation-alb.html.

Several research analysts have recently commented on the company. Royal Bank Of Canada reiterated a “buy” rating and issued a $149.00 price objective on shares of Albemarle Corporation in a report on Wednesday. CIBC assumed coverage on Albemarle Corporation in a report on Thursday, August 17th. They issued an “outperform” rating and a $133.00 price objective on the stock. Piper Jaffray Companies reiterated an “overweight” rating and issued a $47.00 price objective on shares of Albemarle Corporation in a report on Thursday, June 29th. SunTrust Banks, Inc. downgraded Albemarle Corporation from a “buy” rating to a “hold” rating and set a $121.00 price objective on the stock. in a report on Wednesday, August 9th. Finally, Goldman Sachs Group, Inc. (The) downgraded Albemarle Corporation from a “buy” rating to a “neutral” rating and boosted their price target for the company from $139.66 to $142.00 in a report on Friday, October 6th. Eight analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $123.63.

In other news, EVP Karen G. Narwold sold 11,500 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $115.95, for a total transaction of $1,333,425.00. Following the transaction, the executive vice president now directly owns 36,620 shares in the company, valued at $4,246,089. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Matthew Juneau sold 5,397 shares of the stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $115.77, for a total transaction of $624,810.69. Following the transaction, the executive vice president now owns 360 shares in the company, valued at $41,677.20. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by company insiders.

Albemarle Corporation (NYSE ALB) opened at 139.66 on Thursday. Albemarle Corporation has a one year low of $76.32 and a one year high of $140.28. The stock has a market capitalization of $15.43 billion, a price-to-earnings ratio of 17.86 and a beta of 1.67. The company has a 50-day moving average of $130.64 and a 200-day moving average of $116.10.

Albemarle Corporation (NYSE:ALB) last released its quarterly earnings data on Monday, August 7th. The specialty chemicals company reported $1.13 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.02. Albemarle Corporation had a net margin of 31.49% and a return on equity of 11.59%. The firm had revenue of $737.25 million for the quarter, compared to the consensus estimate of $735.50 million. During the same period last year, the firm earned $0.93 earnings per share. The company’s quarterly revenue was up 10.1% on a year-over-year basis. On average, equities analysts forecast that Albemarle Corporation will post $4.38 EPS for the current fiscal year.

About Albemarle Corporation

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle Corporation (NYSE:ALB)

Receive News & Stock Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related stocks with our FREE daily email newsletter.